Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetes

a type 2 diabetes and management program technology, applied in the direction of dna/rna fragmentation, microorganism testing/measurement, biochemistry apparatus and processes, etc., can solve the problems of reducing the use of unnecessary probes and other reagents, affecting the self-management of diabetics, and not reaching all patients.

Inactive Publication Date: 2018-04-05
PATIA BIOPHARMA S A DE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent is about a genotyping tool that uses four specific genetic markers to predict the risk of type 2 diabetes and how well a person will respond to treatment with sulfonylurea drugs. This tool is efficient and effective across different ethnic groups, reducing the need for unnecessary reagents and probes. The genetic markers used in the tool are easily accessible and are conserved across different populations, making them useful for predicting risk and treatment response in a wide range of individuals.

Problems solved by technology

The global epidemic of Type 2 diabetes (T2D) is a major public health problem, as this disease is the fifth leading cause of death worldwide and a leading cause of morbidity, premature coronary heart disease, stroke, peripheral vascular disease, renal failure, and amputation [1].
Most efforts support preventive care with weekly, monthly, or even less frequent contact because frequent contact requires the time of expensive medical professionals.
Nevertheless, there is a serious problem with DSME.
As a group, diabetics do not adhere well to regimented programs.
Furthermore, methods that have proven to be effective in increasing patient adherence to diabetes management programs do not reach all patients.
Thus, the majority of diabetics do not adequately adhere to diabetes management programs or fail at self-management.
Existing programs do not fully meet the needs of these patients; therefore, additional tools and methods to encourage effective self-management are needed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetes
  • Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetes
  • Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetes

Examples

Experimental program
Comparison scheme
Effect test

example 1

of 16 Single Nucleotide Polymorphisms (SNPs) for a Type 2 Diabetes Genetic Prediction Tool in Mexican (and Latino) Populations

[0091]SNPs were prioritized from the largest meta-analyses of extant genome-wide association studies (GWAS) performed in European and other populations, under the assumptions that: (1) their effects in other populations were generalizable and (2) the largest sample sizes available provided the most robust estimates of the true effect size. The SIGMA1 GWAS dataset was used to ensure that the proposed SNPs have consistent effects in the Mexican population. Consideration was made of allele frequencies in Mexicans, to maximize the predictive power of a SNP at the population level (effect size×allele frequency). To maximize flexibility and minimize cost, a single array of 16 SNPs was chosen. It was decided that the array would not include ancestry informative markers.

[0092]SNPs were ranked by their odds ratio in the largest dataset available (Morris et al., Large-...

example 2

Determine the Genetics of Acute Glipizide and Metformin Response in Humans with the HNF1A E50SK Variant

[0106]As described in The SIGMA Type 2 Diabetes Consortium, JAMA, 2014; 311(22), pp. 2305-2314, a mutation in HNF1A was identified, which is present in 2% of people with diabetes studied in Mexico. This mutation is located in exon 8 (E508K), which causes a partial defect in the function of the protein. This finding is consistent with that has been observed in other described mutations of exon 8; and is associated with late-onset diabetes. The initial clinical and biochemical characterization of subjects with the HNF1A E508K mutation showed that carriers of the variant have a clinical profiles indistinguishable from those of patients with Type 2 Diabetes. Pharmacogenetic studies are required to demonstrate that the carriers with the E508K variant selectively respond to sulfonylureas. Testing of this hypothesis has practical implications because it would be possible to propose a simp...

example 3

ions for the Management of Diabetes

Creation of a Basic Mobile Individual Casual Game for Reinforcing Effective Eating Habits and Awareness

[0134]The game would be developed for the Android platform using a touch-based interface. The instructional goal would be to reinforce the benefits of eating the right types of foods. A key intent would be to develop a gameplay style that is “addictive” to encourage long-term gameplay.

[0135]Potential Game Style: Forward-scroller (e.g., Minion Rush) or Side-scroller (e.g., Super Mario Bros), where collecting “good” food makes you stronger and “bad” food makes you weaker. Simple actions (e.g., jump with a slide up of your finger). Perhaps have a special “super food” that lets you power-up and counter the negative effect of a bad food. Reinforce concepts related to blood sugar via meters that go up and down over time or changes in the character's visible appearance. Reinforce the negative aspects of certain key bad foods via related monsters / etc. tha...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
waist circumferenceaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention provides a method of assessing type 2 diabetes susceptibility and / or predicting treatment responsiveness in a human subject, the method comprising determining the identity of at least one allele at each of three or more positions of single nucleotide polymorphism (SNP) selected from the group consisting of: SLC16A11—rs75493593; HNF1A—rs483353044; TCF7L2—rs7903146; CDKN2A / B—rs10811661; CDKAL1—rs7756992; SLC30A8—rs3802177; IGF2BP2—rs4402960; FTO—rs9936385; PPARG—rs1801282; HHEX / IDE—rs1111875; ADCY5—rs11717195; JAZF1—rs849135; WSF1—rs4458523; INS—IGF2—rs149483638; KCNQ1—rs2237897; and KCNJ11—rs5219, and / or an SNP in linkage disequilibrium with any one of said SNPs at r2>0.8. Also provided are a genotyping tool and a type 2 diabetes risk assessment system for use in the method of the invention.

Description

FIELD OF THE INVENTION[0001]The present invention relates to methods and products, in particular arrays and related systems, for in vitro genotyping of type 2 diabetes (T2D) associated genetic variations and to methods for assessment of T2D risk, prevention, management, and treatment selection, including one or more of: assessment of genetic risk for T2D, assessment of sensitivity to diabetes medications, and interventions for supporting diabetes prevention, delay and management, such as mobile individual casual games for reinforcing effective eating habits, virtual longitudinal interactive games, and casual games with real-life behavior assessment, social media networks, and education systems.BACKGROUND TO THE INVENTION[0002]The global epidemic of Type 2 diabetes (T2D) is a major public health problem, as this disease is the fifth leading cause of death worldwide and a leading cause of morbidity, premature coronary heart disease, stroke, peripheral vascular disease, renal failure, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/6883C12Q1/6858C12Q1/6809C12N15/11
CPCC12Q1/6883C12Q1/6858C12Q1/6809C12Q2600/156C12Q2600/118C12Q2600/136C12Q2600/158C12Q2600/172
Inventor BUELA, LAUREANO SIMONZULUETA, MIRELLA G.
Owner PATIA BIOPHARMA S A DE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com